ReviewAntonie van Leeuwenhoek2025
Modern therapeutic strategies to mitigate biofilm-associated infection in livestock organisms.
Review in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Detection to Disruption: A Comprehensive Review of Bacterial Biofilms and Therapeutic Advances.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Biofilm consists of populations of microorganisms encased in an extracellular matrix that the microbes produce themselves and adhere to either a living or non-living surface. When compared to planktonic cells, the intrinsic properties of cells within a film are distinct. There has been a lot of concern about biofilm resistance to antimicrobial drugs recently. It is already established that biofilm linked with soft tissues of livestock organisms can cause multitude of chronic and severe infections and that remains the leading underlying reason why antibiotics get ineffective in combating infections. Eliminating biofilms is an arduous task. Investigations on establishing novel and promising strategies in controlling infections associated with biofilms and fighting the challenge are continuing. To assess the efficacy of these techniques, however, there is necessity of further preclinical research and well-designed multi-center clinical trials. Here, an attempt has been made to explore the detailed mechanisms responsible for the development of biofilm-related drug- resistance as well as the recent advancements in therapeutics and effective strategies against microbial biofilms.
Indexed as
Identifiers
41353689What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.